Avance Biosciences™ is excited to announce that we will be exhibiting at Advanced Therapies USA 2026, taking place November 4–5 in Boston, MA. This premier event brings together leaders across the cell and gene therapy field, from biotech innovators and manufacturers to regulatory experts and investors, to discuss the technologies and strategies shaping the future of advanced therapies. Visit us at Booth #511 to meet our team and discuss how Avance Biosciences can support your next cell or gene therapy program.
Key Topics Covered at the Conference
- Cell therapy and gene modified cell therapy
- Gene therapy development and manufacturing
- Viral vector manufacturing
- Cell therapy manufacturing
- Supply chain and logistics
- Evidence, pricing, and market access
- Innovation showcase: emerging biotech start-ups
Event Details
- Event: Advanced Therapies USA 2026
- Dates: November 4–5, 2026
- Location: Hynes Convention Center, Boston, MA
- Avance Booth: #511
Supporting Cell and Gene Therapy Development
At Advanced Therapies USA 2026, Avance Biosciences will highlight our comprehensive suite of bioanalytical and CMC testing services tailored for advanced therapies, including:
- Cell and Gene Therapy Characterization and Release Testing – Flow cytometry-based immunophenotyping, cell-based potency assays, and molecular testing supporting CAR T-cell and other engineered cell products
- Viral Vector Testing and Characterization – Titer determination, identity confirmation, and purity analysis for AAV, lentiviral, and other viral vector platforms
- Gene Editing On/Off-Target Analysis – NGS-based characterization of intended and unintended editing outcomes, combined with robust bioinformatics
- CMC and Regulatory-Aligned Testing Support – Biodistribution, stability, and comparability studies aligned with evolving regulatory expectations
Visit Us at Booth #511
We invite attendees to stop by Booth #511 to meet our scientific and business development teams and learn how Avance Biosciences supports cell and gene therapy programs from early development through clinical and commercial stages. Our team will be available to discuss project needs, technical challenges, and strategies for generating high-quality, regulatory-ready data.
Advancing Cell and Gene Therapy Together
As the field of cell and gene therapy continues to accelerate toward manufacturing at scale, robust analytical strategies are critical for ensuring product safety, efficacy, and consistency. Avance Biosciences partners with sponsors to deliver high-quality data and scientific insight that help de-risk development and streamline regulatory submissions.
Our capabilities are designed to align with evolving regulatory expectations and support programs from process development through commercial-scale production.
Planning to Attend?
Be sure to visit Booth #511 and discover how Avance Biosciences can support your next breakthrough in cell and gene therapy.
We look forward to connecting with colleagues, collaborators, and new partners in Boston at Advanced Therapies USA 2026.
Accelerate your drug development with Avance Biosciences’ Next-Generation Sequencing (NGS) Center of Excellence, delivering GMP- and GLP-compliant genomics solutions to power your development programs. Our capabilities include Short-read Next-gen Sequencing, Nanopore Third-gen Sequencing, PacBio Third-gen Sequencing, 10X Chromium Single-cell Sequencing, and Mission Bio Tapestri Single-cell Sequencing. Learn more at our NGS Center of Excellence and contact our experts to get started.
